FDA Greenlights Revolutionary Sickle Cell Therapies from Vertex and CRISPR, Cracking $2 Million Cost Conundrum
The FDA approves a new gene therapy, Casgevy, for sickle cell disease in patients aged 12 and older, along with a second treatment, Lyfgenia, offering new options for this life-threatening disorder.
Elizabeth 'Bessie' N. Dewar Nominated by Governor Healey for Massachusetts Supreme Judicial Court
Governor Maura Healey nominates Bessie Dewar for the Massachusetts Supreme Judicial Court, praising her as a consensus builder with extensive experience. Dewar's confirmation is pending review by the Governor's Council.












